Novel and combination therapies for polycythemia... - MPN Voice

MPN Voice

10,596 members14,642 posts

Novel and combination therapies for polycythemia vera and essential thrombocythemia: the dawn of a new era

Manouche profile image
2 Replies

« Promising novel agents in clinical testing include the histone deacetylase inhibitor givinostat, the telomerase inhibitor imetelstat, and the LSD-1 inhibitor IMG-7289 »

tandfonline.com/doi/abs/10....

Written by
Manouche profile image
Manouche
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Chicagopv profile image
Chicagopv

$90 to read the article.

Gabrielle79 profile image
Gabrielle79 in reply to Chicagopv

sci-hub.se/https://www.tand...

You may also like...

Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

extracellular strands of decondensed DNA that complex with histones and others neutrophil granular...

New to Essential Thrombocythemia

essential thrombocythemia even though my bone marrow test and bloodwork said otherwise and no sign...

I'm new to Essential Thrombocythemia

JAK2  Reversible Activation Shows an Essential Requirement for Jak2V617F in MPN

JAK2 can signal in the presence of type I JAK inhibitors » … These data support the notion that...

Serotonin as a therapeutic method for PV associated pruritis

reuptake inhibitors are effective in the treatment of polycythemia vera–associated pruritus...